247 related articles for article (PubMed ID: 32487351)
1. MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.
Hashmi F; Mollapour M; Bratslavsky G; Bourboulia D
Urol Oncol; 2021 Jun; 39(6):316-321. PubMed ID: 32487351
[TBL] [Abstract][Full Text] [Related]
2. FKBP51 promotes invasion and migration by increasing the autophagic degradation of TIMP3 in clear cell renal cell carcinoma.
Mao S; Zhang D; Chen L; Tan J; Chu Y; Huang S; Zhou W; Qin H; Xia Q; Zhao Y; Li R; Qin S; Wei M
Cell Death Dis; 2021 Oct; 12(10):899. PubMed ID: 34599146
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.
Kurban G; Hudon V; Duplan E; Ohh M; Pause A
Cancer Res; 2006 Feb; 66(3):1313-9. PubMed ID: 16452184
[TBL] [Abstract][Full Text] [Related]
4. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics.
Haake SM; Li J; Bai Y; Kinose F; Fang B; Welsh EA; Zent R; Dhillon J; Pow-Sang JM; Chen YA; Koomen JM; Rathmell WK; Fishman M; Haura EB
Clin Cancer Res; 2016 Nov; 22(22):5605-5616. PubMed ID: 27220961
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Kallakury BV; Karikehalli S; Haholu A; Sheehan CE; Azumi N; Ross JS
Clin Cancer Res; 2001 Oct; 7(10):3113-9. PubMed ID: 11595703
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression.
Niland S; Riscanevo AX; Eble JA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008569
[TBL] [Abstract][Full Text] [Related]
8. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
10. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
12. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma.
Lein M; Jung K; Laube C; Hübner T; Winkelmann B; Stephan C; Hauptmann S; Rudolph B; Schnorr D; Loening SA
Int J Cancer; 2000 Mar; 85(6):801-4. PubMed ID: 10709099
[TBL] [Abstract][Full Text] [Related]
13. VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling.
Davidowitz EJ; Schoenfeld AR; Burk RD
Mol Cell Biol; 2001 Feb; 21(3):865-74. PubMed ID: 11154273
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases in renal development.
Haas CS; Gleason B; Lin S; Tramonti G; Kanwar YS
Connect Tissue Res; 2004; 45(2):73-85. PubMed ID: 15763922
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix proteases - cytokine regulation role in cancer and pregnancy.
Huang SC; Sheu BC; Chang WC; Cheng CY; Wang PH; Lin S
Front Biosci (Landmark Ed); 2009 Jan; 14(4):1571-88. PubMed ID: 19273147
[TBL] [Abstract][Full Text] [Related]
16. Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases.
Madzharova E; Kastl P; Sabino F; Auf dem Keller U
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238509
[TBL] [Abstract][Full Text] [Related]
17. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
18. PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.
Petrella BL; Brinckerhoff CE
Cancer Biol Ther; 2009 Jul; 8(14):1389-401. PubMed ID: 19483472
[TBL] [Abstract][Full Text] [Related]
19. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of renal extracellular matrix degradation and interventional effects of Chinese herbal medicine].
Wei QX; Wan YG; Zhao Q; Chen HL; Meng XJ; Yao J
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):533-8. PubMed ID: 23713279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
